Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017
November 06 2017 - 4:05PM
Business Wire
Conference Call and webcast to follow
Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) today
announced that it will release its third quarter 2017 financial
results on Tuesday, November 14, 2017, after the market closes. At
4:30 p.m. Eastern Time Aurinia’s management will host a conference
call to discuss the company’s financial results for the third
quarter 2017 and provide a general business update.
The conference call and webcast is scheduled for November 14,
2017 at 4:30pm EST. In order to participate in the conference call,
please dial +1-877-407-9170 (Toll-free U.S. & Canada). An audio
webcast can be accessed under "News/Events” through the “Investors”
section of the Aurinia corporate website at www.auriniapharma.com.
A replay of the webcast will be available on Aurinia’s website.
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is currently developing voclosporin, an investigational drug, for
the treatment of LN, FSGS, MCD and DES. The company is
headquartered in Victoria, BC and focuses its development efforts
globally. For further information, see our website at
www.auriniapharma.com.
We seek safe harbor.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171106006251/en/
Aurinia Pharmaceuticals Inc.Investor Contact:Celia
EconomidesVP, Corporate & Public
AffairsIR@auriniapharma.comorMedia:Christopher Hippolyte, ,
212-364-0458Christopher.hippolyte@inventivhealth.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Sep 2023 to Sep 2024